DBV Technologies (XPAR:DBV) Total Assets : €83.84 Mil (As of Sep. 2024)

View and export this data going back to 2012. Start your Free Trial

What is DBV Technologies Total Assets?

DBV Technologies's Total Assets for the quarter that ended in Sep. 2024 was €83.84 Mil.

During the past 12 months, DBV Technologies's average Total Assets Growth Rate was 10.30% per year. During the past 3 years, the average Total Assets Growth Rate was -15.10% per year. During the past 5 years, the average Total Assets Growth Rate was -9.20% per year. During the past 10 years, the average Total Assets Growth Rate was 18.50% per year.

During the past 13 years, DBV Technologies's highest 3-Year average Total Assets Growth Rate was 65.00%. The lowest was -20.70%. And the median was 33.40%.

Total Assets is connected with ROA %. DBV Technologies's annualized ROA % for the quarter that ended in Sep. 2024 was -115.53%. Total Assets is also linked to Revenue through Asset Turnover. DBV Technologies's Asset Turnover for the quarter that ended in Sep. 2024 was 0.00.

DBV Technologies Total Assets Historical Data

The historical data trend for DBV Technologies's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DBV Technologies Total Assets Chart

DBV Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

244.55

223.79

129.85

232.71

167.80

DBV Technologies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial															177.83	167.80	134.22	106.08	83.84

DBV Technologies Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

DBV Technologies's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	128.551	+	39.247
	=	167.80

DBV Technologies's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2024 )	+	Total Liabilities (Q: Sep. 2024 )
	=	48.685	+	35.158
	=	83.84

DBV Technologies (XPAR:DBV) Total Assets Explanation

Total Assets is connected with ROA %.

DBV Technologies's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %	=	Net Income (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	-109.712	/	( (106.083	+	83.843)	/ 2 )
	=	-109.712	/	94.963
	=	-115.53 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

DBV Technologies's Asset Turnover for the quarter that ended in Sep. 2024 is

	Asset Turnover
=	Revenue (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
=	0	/	( (106.083	+	83.843)	/ 2 )
=	0	/	94.963
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

DBV Technologies Total Assets Related Terms

Thank you for viewing the detailed overview of DBV Technologies's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

DBV Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DBV Technologies SA (XPAR:DBV) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

DBVTF:USA DBVT:USA 0QAJ:UK DBV:Germany

Address

177-181 avenue Pierre Brossolette, Montrouge, FRA, 92120

Website

http://www.dbvtechnologies.com

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.